Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Visit the company website

 

Bullboard - Investor Discussion Forum Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical... see more

TSXV:VM - Post Discussion

Voyageur Pharmaceuticals Ltd > Investors Mislead
View:
Post by WarrantOfficer on Nov 18, 2020 9:12pm

Investors Mislead

To withdrawl a corporate presentation and inform present / future investors not to make any relevance to it is alarming, specifically to those whom have already invested based on this presentation. As for the C60 project claiming they have exclusive rights to one of the worlds rarest pharamceutical minerals and then claim that they have no rights to it at all is nothing short of fraudulent. 

 

Comment by Farmer9 on Nov 18, 2020 11:02pm
A very strange news release to say the least.  Has management lost ALL credibility now?  Who is going to pump money into this company with these clowns running the show?
Comment by postie1 on Nov 20, 2020 11:45am
Will not tell others what to do . I will say that I am holding and right now I see no reason to sell.. That could change but I will not part with my shares over trolls(not you guys) trying to get my shares on the cheap. It was quite a shocker but there has not been a big sell off but just a price drop on small volume. I am going to let the CEO have his say to explain things including money raising ...more  
Comment by WarrantOfficer on Nov 21, 2020 8:39am
Postie1: I concur, no reason to sell off. It is the credability of management that is being brought into the limelight. Publically stating that Voyageur secures exclusive rights to one of the worlds rarest pharma minerals than back tracking and stating it does not and never had...that is just to big of a mistake not to be taken seriously. Brings forth the possibility further claims may not be as ...more  
Comment by postie1 on Nov 21, 2020 9:36am
Best i can make of things is that Vm has not ceased that letter of intent but has put it on hold until after the Covid is done so work can resume to see how viable it is. My biggest concern is the delay on the Iodine property because of law suit that should be settled in 1st quarter 2021. That should not stop the manufacturing of Iodine contrast but the earth to earth is where the best bang for ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.VM

follow v.vm on


Voyageur Pharmaceuticals Deck 2024..

The Watchlist

Voyageur Pharmaceuticals | The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

COMPELLING
VALUE PROPOSITION

  • Only pharmaceutical company in the world that owns long-term supply of barium and iodine
  • Natural barium and iodine resources meet increasingly limited global supply and risk
  • Multi-billion-dollar global market for contrast media
  • Poised to obtain significant market share by offering high-quality, lower-cost products
  • Favorable regulatory pathway allows rapid commercialization
  • Highly experienced team has positioned the company for profitable commercial success

Contact Us

Brent Willis, CEO
Brent@Vpharma.ca

Address:
Suite 1600 Dome Tower, 333 7th Avenue S.W.
Calgary, Alberta
T2P 2Z1